Seegene and Shimadzu Form Partnership for Pathogen Detection
Seegene, Inc. (Rockville, Maryland) and Shimadzu Corporation (Columbia, Maryland) announced that they had formed a strategic partnership to combine Seegene's Seeplex multipathogen tests with Shimadzu's MultiNA high-speed electrophoresis system.
Seegene, Inc. (Rockville, Maryland) and Shimadzu Corporation (Columbia, Maryland) announced that they had formed a strategic partnership to combine Seegene's Seeplex multipathogen tests with Shimadzu's MultiNA high-speed electrophoresis system. The companies will collaborate on integrating the polymerase chain reaction-based tests with the electrophoresis system to provide a highly sensitive, high-throughput detection and analysis system. The microchip electrophoresis system is designed for DNA and RNA nucleic acid size confirmation and quantification, and the tests reportedly are capable of detecting multiple pathogens in a single tube, including STDs, respiratory viruses, human papillomaviruses, sepsis, and pneumonia.
Fundamentals of Benchtop GC–MS Data Analysis and Terminology
April 5th 2025In this installment, we will review the fundamental terminology and data analysis principles in benchtop GC–MS. We will compare the three modes of analysis—full scan, extracted ion chromatograms, and selected ion monitoring—and see how each is used for quantitative and quantitative analysis.
Characterizing Plant Polysaccharides Using Size-Exclusion Chromatography
April 4th 2025With green chemistry becoming more standardized, Leena Pitkänen of Aalto University analyzed how useful size-exclusion chromatography (SEC) and asymmetric flow field-flow fractionation (AF4) could be in characterizing plant polysaccharides.
This information is supplementary to the article “Accelerating Monoclonal Antibody Quality Control: The Role of LC–MS in Upstream Bioprocessing”, which was published in the May 2025 issue of Current Trends in Mass Spectrometry.
